AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05915169 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical haemoglobin wound care spray
Description: It is a wound care spray used in the care of chronic wounds.
Study NCT04987970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(2)
Description: QD, PO
Study NCT04987970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: QD, PO
Study NCT06114654 — intervention group
Intervention type: BEHAVIORAL
Intervention: Physical Therapy
Description: Specific physical tests to assess muscle strength, ankle stability and activation of the lower extremity musculature: Single Leg Stance Test, Hurdle Step test and Single leg vertical jump.
Study NCT05328544 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction of the knee joint by arthroscopic technique, with the tibial fixation method using a bioabsorbable screw (Arthrex) with the use of autogenous cancellous bone grafts
Description: Reconstruction of the anterior cruciate ligament (ACL) of the joint the knee stabilization method, a bioabsorbable screw with the use of an autogenous spongy bone graft taken during drilling of the tibial canal into the tibial canate before inserting the screw.
Study NCT05328544 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ACL reconstruction of the knee joint by arthroscopic technique, with the tibial fixation method using a bioabsorbable screw (Arthrex) without the use of autogenous cancellous bone grafts
Description: Reconstruction of the anterior cruciate ligament (ACL) of the joint the knee stabilization method, a bioabsorbable screw without the use of an autogenous spongy bone graft taken during drilling of the tibial canal into the tibial canate before inserting the screw.
Study NCT06413407 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tai Chi Exercise
Description: Tai Chi Exercise will be applied to this group.
Study NCT06413407 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Receptive Music Therapy
Description: Receptive Music Therapy will be applied to this group.
Study NCT06413407 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Tai Chi Exercise and Receptive Music Therapy techniques will be applied together to this group.
Study NCT04743596 — intervention group
Intervention type: DEVICE
Intervention: High-Definition Videobronchoscopy
Description: Endoscopic inspection and endobronchial biopsy with standard forceps during high-definition videobronchoscopy.
Study NCT06494813 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: conventional pcr
Description: conventional pcr to study matrix metalloproteinase -9 gene polymorphismin rheumatoid arthritis
Study NCT05368506 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Wee1 Inhibitor ZN-c3
Description: Given PO
Study NCT05435235 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg Tab
Description: One tablet daily starting 48h prior to PCI and continuing for 48h post-PCI.
Study NCT05971329 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cervical Fusion (ZetaFuse™ Bone Graft)
Description: Fusion of the C3-C7 cervical vertebral bodies
Study NCT05948462 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lorlatinib
Description: Participants will receive assigned dose of daily oral lorlatinib continuously for each cycle. Each cycle is 3 weeks.
Study NCT05948462 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin or Carboplatin
Description: Participants will receive standard of care intravenous Cisplatin or Carboplatin, both chemotherapy medications, on day 1 of each cycle every 3 weeks, for Cycles 1-4. Each cycle is 3 weeks.
Study NCT05948462 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Participants will receive intravenous Pemetrexed, a chemotherapy medication, on day 1 of each cycle. Each cycle is 3 weeks.
Study NCT04315714 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga Program
Description: Six-week, twice weekly, 60-minute private yoga program (delivered online/virtually via Zoom).
Study NCT06313034 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breastfeeding education based on motivational interviewing technique
Description: Breastfeeding education based on motivational interviewing technique; Breast milk properties, benefits to mother and baby, breastfeeding positions, the relationship between breastfeeding and attachment, signs of hunger in the newborn, Breastfeeding frequency, duration and termination, Breast milk expressing methods, Expressions showing that the newborn has enough milk, Breast milk storage will cover the topics. These topics will be given based on motivational interviewing technique.~According to the motivational interviewing technique, the mother's intention, importance and confidence-sufficiency regarding breastfeeding will be determined and firstly, an agenda will be created on issues related to breastfeeding with the mother. Each session will be conducted by following the open-ended questioning, verification, reflective listening and summarizing approaches of the motivational interviewing technique.
Study NCT05013463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine Pill
Description: Oral Hydroxychloroquine, 200mg BID
Study NCT05013463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indapamide Pill
Description: Oral Indapamide, 2.5 mg OD
Study NCT04726163 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous blind glucose measurement device (Free style Pro)
Description: A continuous blind glucose measurement device (Free style Pro) will be set up on the first day and throughout the entire hospital stay
Study NCT05812703 — intervention group
Intervention type: BEHAVIORAL
Intervention: Cognitive Behavioral Therapy
Description: The participants will attend one of the behavioral group treatments programs offered by the Stanford Pain Management Center. This class may be held online via Zoom, or in person based at the Stanford Pain Management Center. The class may be recorded for training purposes. No names or images/faces will be recorded for privacy reasons. The behavioral groups are 3 types, with or without exercise/movement. Current Evidence Based treatments that are provided as standard practice include: Cognitive Behavioral Therapy Group, with movement, Acceptance and Commitment Therapy Group, with or without movement. Group participants will learn different skills in each group and develop a personalized plan to use the skills after group ends. At the end of group participants will be given an anonymous survey about the class to evaluate satisfaction of the treatment. Movement in this portion of class is designed to low impact and restorative/gentle, with no significant increases in HR > 50% HRmax.
Study NCT05812703 — intervention group
Intervention type: BEHAVIORAL
Intervention: Acceptance and Commitment Therapy (ACT)
Description: ACT is a 6 week behavioral group program led by a psychologist to improve psychological flexibility and reduce pain interference in patients with chronic pain.
Study NCT06275321 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Synchronous-supervised online home-based group
Description: An online exercise program combining endurance and strength training
Study NCT06275321 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise recommendation group
Description: General recommendation about physical exercise. No supervised
Study NCT06434753 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Zinc Acexamate
Description: The experimental group will receive ACZ at a daily dose of 600 mg, equivalent to 100mg of elemental zinc (one hard gelatin capsule of 300 mg of ACZ twice a day). Treatment will be stopped when the patient presents any of the events that define the main endpoint of the study.~The control group will receive twice a day orally hard gelatin capsules, identical to those of ACZ, in color, weight and nature, but containing an inert preparation (isomaltose).
Study NCT06434753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc Acexamate
Description: The experimental group will receive ACZ at a daily dose of 600 mg, equivalent to 100mg of elemental zinc (one hard gelatin capsule of 300 mg of ACZ twice a day). Treatment will be stopped when the patient presents any of the events that define the main endpoint of the study.~The control group will receive twice a day orally hard gelatin capsules, identical to those of ACZ, in color, weight and nature, but containing an inert preparation (isomaltose).
Study NCT04936581 — intervention group
Intervention type: PROCEDURE
Intervention: Open Total Mesorectal Excision
Description: Open approach for Total Mesorectal Excision
Study NCT04936581 — intervention group
Intervention type: PROCEDURE
Intervention: Laparoscopic Total Mesorectal Excision
Description: Laparoscopic approach for Total Mesorectal Excision
Study NCT05812703 — intervention group
Intervention type: BEHAVIORAL
Intervention: Moderate to high Intensity Group Exercise
Description: Group exercise led by supervised clinician with Cardiovascular focus to increase HR into zones to see adaptations to improve cardiovascular fitness.
Study NCT04724720 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Famotidine
Description: Standard or care treatment plus prescribed famotidine
Study NCT04724720 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Standard of care treatment plus placebo
Study NCT06085066 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Ultrafiltration alone on Cardiopulmonary bypass
Description: Conventional Ultrafiltration was used on Cardiopulmonary bypass for patients who underwent open heart surgery
Study NCT06085066 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Ultrafiltration followed by Modified Ultrafitration on Cardiopulmonary bypass
Description: Modified Ultrafiltration was used following the Conventional Ultrafiltration on Cardiopulmonary bypass for patients who underwent open heart surgery
Study NCT04936581 — intervention group
Intervention type: PROCEDURE
Intervention: Robotic Total Mesorectal Excision
Description: Robotic approach for Total Mesorectal Excision
Study NCT04936581 — intervention group
Intervention type: PROCEDURE
Intervention: Transanal Total Mesorectal Excision
Description: Transanal approach for Total Mesorectal Excision
Study NCT05039112 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Verofilcon A toric contact lenses
Description: Soft contact lenses for optical correction of astigmatism, used as indicated
Study NCT05039112 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Stenfilcon A toric contact lenses
Description: Soft contact lenses for optical correction of astigmatism, used as indicated
Study NCT05925010 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Supplementation with soluble fibre from guar (Optifibre©)
Description: 10g of soluble fibre from guar in the form of Optifibre© (dietary food for special medical purposes) is added to the standardized meal (Resource cereal porridge©).
Study NCT05921227 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VAULT Phase 6
Description: VAULT is an input-based word learning intervention based on principles of statistical learning.
Study NCT05921227 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: VAULT Phase 6
Description: VAULT is an input-based word learning intervention based on principles of statistical learning.
Study NCT05187923 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Artificial Intelligence Algorithm
Description: Different machine learning and deep learning computer aided strategies for model construction and validation.
Study NCT06187441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab Injection
Description: Patients who have been treated with 12 cycles of Daratumumab-Lenalidomide-Dexamethasone (Dara-Rd) will be randomized between Arm A (continuous therapy) and Arm B (treatment free interval)
Study NCT06187441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Patients who have been treated with 12 cycles of Daratumumab-Lenalidomide-Dexamethasone (Dara-Rd) will be randomized between Arm A (continuous therapy) and Arm B (treatment free interval)
Study NCT06187441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide capsule
Description: Patients who have been treated with 12 cycles of Daratumumab-Lenalidomide-Dexamethasone (Dara-Rd) will be randomized between Arm A (continuous therapy) and Arm B (treatment free interval)
Study NCT04871438 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flash glucose monitoring
Description: Group A will use FreeStyle Libre for two weeks of FGM-based titration of medications at two time-points: 1) At recruitment and 2) At 6 weeks. Outside of these time points, they will use SMBG (standard care) for monitoring of blood glucose.
Study NCT05831449 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Local anesthetic injection of CPL-01
Description: Local anesthetic injection (either IP, positive control \[Naropin\], or negative control \[saline placebo\])
Study NCT05831449 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naropin, 0.5% Injectable Solution
Description: Local anesthetic injection (either IP, positive control \[Naropin\], or negative control \[saline placebo\])
Study NCT05831449 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Local anesthetic injection (either IP, positive control \[Naropin\], or negative control \[saline placebo\])
Study NCT04543682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.125 ng/kg/min Iloprost
Description: Drug administration through a catheter (inserted at the end of the surgical procedure) begins 24±2 hours after surgery: 0.125 ng/kg/min Iloprost for a duration of 24 hours
Study NCT04543682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.25 ng/kg/min Iloprost
Description: Drug administration through a catheter (inserted at the end of the surgical procedure) begins 24±2 hours after surgery: 0.25 ng/kg/min Iloprost for a duration of 24 hours
Study NCT04543682 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: open reduction and internal fixation with an angular stable plate (PHILOS)
Description: open reduction and internal fixation with an angular stable plate (PHILOS)
Study NCT04543682 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: open reduction and internal fixation with an angular stable plate (PHILOS)
Description: open reduction and internal fixation with an angular stable plate (PHILOS)
Study NCT05294731 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGB-16673
Description: Orally administered
Study NCT06258278 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic-assisted lower trapezius tendon transfer surgery
Description: The procedure, conducted under general anesthesia, starts with diagnostic arthroscopy followed by excision of the posterior bursa and preparation of the rotator cuff footprint. Attention then shifts to harvesting the low trapezius tendon, accessed through a 10cm incision over the spina scapula. The tendon is detached, dissected, and released from adhesions, ensuring not to damage its pedicle. A fascia lata graft is harvested from the ipsilateral thigh and sutured to the low trapezius tendon in a continuous, locking manner to aid fixation on the humeral head. A subdeltoid tunnel is formed, and the graft is shuttled into the subacromial space and fixed at the bicipital groove and tuberculum majus with knotless anchors. The stability of fixation and mobility of the low trapezius muscle are verified, and the graft and tendon are sutured together with tension, with the arm held in 90° abduction and maximum external rotation.
Study NCT04767880 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey
Description: Doses of 10, 15, 20 and 30 gram protein of a regular whey protein compound (whey protein isolate WPI (Lacprodan® ISO.Water. from Arla Foods Ingredients))
Study NCT04767880 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo contains \<1 kcal and 0 g protein
Study NCT05393154 — intervention group
Intervention type: DEVICE
Intervention: Biopsy Adequacy Evaluation by Aquyre Biopsy Scanner
Description: Microscopic viewing and imaging of Bronchoscopic Biopsy Specimens using Full Field Optical Coherence Tomography and Dynamic Cell Imaging
Study NCT04590612 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet
Description: 25mg-100mg tablets to be taken orally three times a day on an empty stomach
Study NCT04590612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citalopram
Description: 20 mg tablet to be taken orally once and at the same time of the day, daily.
Study NCT06435715 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 10 Repetitions of Deep Breathing Exercise
Description: Respondents in the intervention group performed 10 repetitions of deep breathing exercises every 3 hours for 3 days.
Study NCT04855227 — intervention group
Intervention type: PROCEDURE
Intervention: robotic-assisted ventral hernia repair
Description: Laparoscopic ventral hernia repair With the subject under general anesthesia, several small incisions are made in the abdomen. Ports are placed, the abdomen is insufflated, and laparoscopic instruments as well as a laparoscope are inserted to complete the repair. The retrorectus space is developed for mesh placement to repair the defect. The repair technique will be per the surgeon's standard of care.~Robotic-assisted ventral hernia repair With the patient under general anesthesia, several small incisions are made in the abdomen. Ports are placed, the abdomen is insufflated, and the da Vinci Robotic Surgical System (Intuitive) is docked to the subject and used to complete the procedure. The retrorectus space is developed for mesh placement to repair the defect. The repair technique will be per the surgeon's standard of care.
Study NCT04396873 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 11C-MC1
Description: Injected IV followed by PET scanning
Study NCT04396873 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 11C-PS13
Description: Injected IV followed by PET scanning
Study NCT04396873 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 18f-florbetaben
Description: Injected IV followed by PET scanning
Study NCT06237049 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2 (Omi XBB.1.5)/RIV
Description: Combination of BNT162b2 (Omi XBB.1.5) and RIV
Study NCT06237049 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2 (Omi XBB.1.5)
Description: Licensed COVID-19 vaccine
Study NCT06237049 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BNT162b2 (Omi XBB.1.5)
Description: Licensed COVID-19 vaccine
Study NCT06237049 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RIV
Description: Licensed recombinant influenza vaccine
Study NCT06237049 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: RIV
Description: Licensed recombinant influenza vaccine
Study NCT06237049 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Normal saline placebo
Description: Normal saline (solution for injection)
Study NCT06237049 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Normal saline placebo
Description: Normal saline (solution for injection)
Study NCT05521984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Commercially available
Study NCT05521984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carmustine
Description: Standard of care
Study NCT05521984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topotecan
Description: Standard of care
Study NCT05521984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Standard of care
Study NCT05324501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MTX110
Description: Soluble panobinostat
Study NCT05324501 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Programmable pump and catheter system
Description: To allow Convection-Enhanced Delivery (CED)
Study NCT05686122 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PainPac
Description: Patient-focused behavioral pain intervention delivered via mobile application.
Study NCT00629213 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: acarbose
Study NCT06435715 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 3 Repetitions of Deep Breathing Exercise
Description: Respondents in the control group performed 3 repetitions of deep breathing exercises for 3 days.
Study NCT05246280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TC99m-tilmanocept
Description: Tilmanocept is a radiotracer that accumulates in macrophages by binding to a mannose binding receptor that resides on the surface.
Study NCT05127265 — intervention group
Intervention type: OTHER
Intervention: Video Monitoring
Description: continuous video monitoring
Study NCT05127265 — intervention group
Intervention type: OTHER
Intervention: Accelerometer Monitoring
Description: continuous accelerometer monitoring of patient movements
Study NCT05127265 — intervention group
Intervention type: OTHER
Intervention: Noise Level Monitoring
Description: continuous environmental noise monitoring
Study NCT05127265 — intervention group
Intervention type: OTHER
Intervention: Light Level Monitoring
Description: continuous environmental light monitoring
Study NCT05127265 — intervention group
Intervention type: OTHER
Intervention: Air Quality Monitoring
Description: continuous environmental air quality monitoring
Study NCT05127265 — intervention group
Intervention type: OTHER
Intervention: EKG Monitoring
Description: continuous EKG monitoring